(Q28487731)

English

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa (English)

0 references

0 references

0 references

extensively drug-resistant tuberculosis

1 reference

based on heuristic

inferred from title

Paul van Helden

11

0 references

Elize Pieterson

3

0 references

16

0 references

Elizabeth Streicher

2

0 references

Rannakoe Lehloenya

7

0 references

Xavier Padanilam

8

0 references

6

0 references

Richard van Zyl Smit

5

0 references

Robin M. Warren

object named as

Robin Warren

14

0 references

Martin Peter Grobusch

12

object named as

Martin P Grobusch

0 references

author name string

Karen Shean

1

0 references

Greg Symons

4

0 references

Grant Theron

6

0 references

Paul Wilcox

9

0 references

Tommie C Victor

10

0 references

Martin Groubusch

13

0 references

Motasim Badri

15

0 references

language of work or name

0 references

publication date

2013

0 references

0 references

8

0 references

5

0 references

e63057

0 references

copyright license

Creative Commons Attribution 4.0 International

7 May 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

19 March 2017

Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

7 April 2017

Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

29 September 2017

Extensively drug-resistant tuberculosis: epidemiology and management challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

29 September 2017

Using a label-free proteomics method to identify differentially abundant proteins in closely related hypo- and hypervirulent clinical Mycobacterium tuberculosis Beijing isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

29 September 2017

Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

29 September 2017

Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

29 September 2017

Comprehensive treatment of extensively drug-resistant tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

29 September 2017

Spoligotype signatures in the Mycobacterium tuberculosis complex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

29 September 2017

Side effects associated with the treatment of multidrug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

29 September 2017

Hypokalemia among patients receiving treatment for multidrug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

29 September 2017

Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

29 September 2017

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0063057

21 January 2018

Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0063057

21 January 2018

Safe Mycobacterium tuberculosis DNA extraction method that does not compromise integrity

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0063057

21 January 2018

Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0063057

21 January 2018

Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

27 November 2018

Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646906

27 November 2018

Adverse drug reactions associated with first-line anti-tuberculosis drug regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/23667572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23667572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0063057

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2013PLoSO...863057S

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28487731&oldid=1998143383"